Literature DB >> 6627640

Time-course of cigarette smoke contamination of clinical hydrogen breath-analysis tests.

A Rosenthal, N W Solomons.   

Abstract

The time-course of the contamination of exogenous hydrogen from cigarette smoke on postprandial breath hydrogen concentration was evaluated in 10 subjects, six regular smokers and four occasional smokers. Breath hydrogen values were determined by gas chromatography 10 min, 5 min, and immediately prior to smoking a filter cigarette; during smoking from a sample of exhaled air containing smoke; and 5, 10, and 15 min after extinguishing the cigarette. A three- to 137-fold increase above basal hydrogen concentrations was produced by exhaled cigarette smoke, but most subjects had re-equilibrated to baseline values within 10 to 15 min after the cigarette. If subjects undergoing clinical hydrogen breath tests cannot refrain from smoking during the duration of the test, one should allow an interval of at least 15 min from the end of smoking to the collection of a breath sample.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627640

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  14 in total

1.  Cigarette smoking and nicotine delay postprandial mouth-cecum transit time.

Authors:  A M Scott; J E Kellow; G M Eckersley; J M Nolan; M P Jones
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Prevalence and consistency of low breath H2 excretion following lactulose ingestion. Possible implications for the clinical use of the H2 breath test.

Authors:  G Corazza; A Strocchi; M Sorge; G Bentai; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

3.  The inulin hydrogen breath test predicts the quality of colonic preparation.

Authors:  Donato F Altomare; Leonilde Bonfrate; Marcin Krawczyk; Frank Lammert; Onofrio Caputi-Jambrenghi; Salvatore Rizzi; Michele Vacca; Piero Portincasa
Journal:  Surg Endosc       Date:  2014-01-01       Impact factor: 4.584

4.  Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome.

Authors:  Michele Di Stefano; Paola Tana; Caterina Mengoli; Emanuela Miceli; Elisabetta Pagani; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2010-12-16       Impact factor: 3.397

5.  Breath Methane Excretion Is not An Accurate Marker of Colonic Methane Production in Irritable Bowel Syndrome.

Authors:  Michele Di Stefano; Caterina Mengoli; Manuela Bergonzi; Catherine Klersy; Elisabetta Pagani; Emanuela Miceli; Gino Roberto Corazza
Journal:  Am J Gastroenterol       Date:  2015-03-24       Impact factor: 10.864

6.  Small intestine bacterial overgrowth and metabolic bone disease.

Authors:  M Di Stefano; G Veneto; S Malservisi; G R Corazza
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

7.  Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon.

Authors:  Antonio Tursi; Giovanni Brandimarte; Gian Marco Giorgetti; Walter Elisei
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

8.  The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms.

Authors:  Michele Di Stefano; Emanuela Miceli; Samantha Gotti; Antonio Missanelli; Samanta Mazzocchi; Gino Roberto Corazza
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.199

9.  Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.

Authors:  Ali Rezaie; Michelle Buresi; Anthony Lembo; Henry Lin; Richard McCallum; Satish Rao; Max Schmulson; Miguel Valdovinos; Salam Zakko; Mark Pimentel
Journal:  Am J Gastroenterol       Date:  2017-03-21       Impact factor: 10.864

10.  Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.

Authors:  Agostino Di Ciaula; Michele Covelli; Massimo Berardino; David Q H Wang; Giovanni Lapadula; Giuseppe Palasciano; Piero Portincasa
Journal:  BMC Gastroenterol       Date:  2008-02-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.